The company in question is, CR Bard Inc. (NYSE:BCR) currently with a stock price of 219.8 (0.52% today). The market cap for CR Bard Inc. is 16265.2, and is in the sector Healthcare, and Medical Instruments & Supplies industry. The target price for CR Bard Inc. is 241.86. Currently CR Bard Inc. is trading with a P/E of 43.41, and a forward P/E of 19.41. Average volume for CR Bard Inc. is 463.58 and so far today it is 450800.
Performance in the last year for CR Bard Inc. has been 14.47%. For EPS growth, CR Bard Inc. has seen a growth of -52.90%, and is looking to grow in the next year to 11.35%. More long term stats show that EPS growth has been -19.80% over the last five years and could be 10.87% for the next five years. CR Bard Inc. has seen sales growth quarter over quarter at -44.50%, with EPS growth quarter over quarter at 83.50%. The 20-day simple moving average is -0.81%, with the 200-day simple moving average coming to 4.32%.
Since the IPO date for CR Bard Inc. on the 4/6/1983, CR Bard Inc. has seen performance year to date to be 16.45%. With CR Bard Inc. trading at 219.8, the dividend yield is 0.47%, and the EPS is 5.06.
So could CR Bard Inc., be undervalued? Well as said before P/E is 43.41. The PEG is 3.99, P/S is 4.59 and the P/B is at 9.99. The P/cash is 20.39, with P/free cash flow at 55.99.
CR Bard Inc. ability to deal with debt shows that the current ratio is 2.4, and the quick ratio is 1.9. This is with long term debt/equity at 1.01, and total debt/equity at 1.01.
In terms of margins, CR Bard Inc. has a gross margin of 62.50%, an operating margin of 14.10% and a profit margin of 9.10%.Payout ratio for CR Bard Inc. is 22.00%. Return on assets come to 6.30% with return on investment coming to 6.40%.
Insider ownership for CR Bard Inc., is at 0.30% and institutional ownership comes to 90.50%. Outstanding shares are at 74. While shares float is 73.21. The float short is currently 2.27%, and short ratio is 3.59.